Dr. Adas Darinskas
Dr. Adas Darinskas, PhD
Biomedical scientist · Lithuania
E-mail: darinskas.adas@gmail.com
Dr. Adas Darinskas is a Lithuanian biomedical scientist specializing in advanced therapy medicinal products (ATMPs/iATMPs), cell technologies, tissue banking and regenerative medicine. He combines laboratory leadership, GMP manufacturing, quality control and research collaboration with Lithuanian and international partners.
Current roles (selected)
- Head of the Laboratory, CMB medicina JSC (2020–present)
- Head of Manufacturing / Certifying Person / Qualified Person / Head of R&D, Froceth JSC (2014–present)
- Researcher and Certifying Person, National Cancer Institute (2012–present)
- Head of the Laboratory, Imunolita JSC (2006–present)
- Deputy Director / CEO, Innovita Research JSC (2005–present)
Previous experience (selected)
- Quality Control Specialist, Profarma JSC (2020–2022) and Cellin Technologies OÜ (2019–2021)
- Manufacturing / ATMP Specialist, Cellthera Ltd (2010–2014)
Education
- PhD in Biomedical Sciences, Vilnius University, Institute of Immunology (2002–2008)
- Postdoctoral internship, Kaunas Medical University Institute of Cardiology — stem cell laboratory & tissue engineering (2009–2011)
- MSc Botany and BSc Molecular Biology, Vilnius University, Faculty of Natural Sciences
- Free listener, Pharmacy studies, Lithuanian University of Health Sciences (2020–2021)
Expertise
Stem cell isolation and culture, tissue engineering, flow cytometry, molecular biology, ATMP/iATMP development, validation and production under GMP, qualified person responsibilities, and scientific project leadership in oncology, immunotherapy and regenerative applications.
Languages
Lithuanian (native); Russian and English (C2); Polish (B1–B2).